Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Dasatinib (Excl. Strength 100 Mg In Standard Sizes N2 And N3, Atc L01Ea02 For The Period 01.11.24 - 31.10.26